A protected cell company, LB2 was set up in August 2022 with Ariel Re the first sponsor to raise capital through the structure. Since then, it has secured a further $270 million in capital for Syndicate 1910 and SPA 6136 from five new investors.
On 18 April 2023, Artex hosted a webinar, in partnership with Lloyd's and Ariel Re, titled Optimising Access to Lloyd's Through London Bridge 2 PCC Ltd (LB2). It aimed to educate participants on the risk transformation platform and showcase the ways in which investors can increase their participation in the Lloyd's market.
Much was covered during the well-attended hour-long webinar discussion, but our experts didn't have time to fully answer a number of outstanding questions.
In this Q&A, compiled after the event, Des Potter, special advisor to Lloyd's, Tim Shreeve, head of platform development at Ariel Re, and Ed Saul, VP of insurance management at Artex Capital Solutions (ACS) go into more detail on the mechanics and structure of LB2, and its position within the global insurance-linked securities (ILS) market. And they also set the record straight on the ease of entering into ILS transactions that have a uniquely Lloyd's flavour.
You can access the PDF of the full Q&A below. You can also watch the April 18, 2023 webinar on demand.
Author Information
